Global burden of skin disease: inequities and innovations

D Seth, K Cheldize, D Brown, EE Freeman - Current dermatology reports, 2017 - Springer
Abstract Purpose of Review We review the current understanding of the burden of
dermatological disease through the lens of the Global Burden of Disease project, evaluate …

Visceral leishmaniasis: recent advances in diagnostics and treatment regimens

J van Griensven, E Diro - Infectious Disease Clinics, 2019 - id.theclinics.com
Visceral leishmaniasis (VL) is a disseminated protozoan infection caused by Leishmania
donovani and Leishmania infantum. 1 Exceptionally, dermatotropic species can visceralize …

Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical …

N Aronson, BL Herwaldt, M Libman… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that leishmaniasis guidelines cannot always account for individual
variation among patients. They are not intended to supplant physician judgment with respect …

[HTML][HTML] Leishmaniasis diagnosis: an update on the use of parasitological, immunological and molecular methods

S Thakur, J Joshi, S Kaur - Journal of Parasitic Diseases, 2020 - Springer
Diagnosis of leishmaniasis has always been a major challenge as its clinical features
resemble some other commonly occurring diseases such as tuberculosis, typhoid, and …

Diagnosis of leishmaniasis

EK Elmahallawy, AS Martínez… - The Journal of Infection …, 2014 - jidc.org
Leishmaniasis is a clinically heterogeneous syndrome caused by intracellular protozoan
parasites of the genus Leishmania. The clinical spectrum of leishmaniasis encompasses …

Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease

M Boelaert, K Verdonck, J Menten… - Cochrane database …, 2014 - cochranelibrary.com
Background The diagnosis of visceral leishmaniasis (VL) in patients with fever and a large
spleen relies on showing Leishmania parasites in tissue samples and on serological tests …

[HTML][HTML] Laboratory diagnosis of cutaneous and visceral leishmaniasis: current and future methods

JQ Reimão, EM Coser, MR Lee, AC Coelho - Microorganisms, 2020 - mdpi.com
Leishmaniasis is a neglected tropical disease with two main clinical forms: cutaneous and
visceral leishmaniasis. Diagnosis of leishmaniasis is still a challenge, concerning the …

Leishmaniasis immunopathology—impact on design and use of vaccines, diagnostics and drugs

PM Kaye, I Cruz, A Picado, K Van Bocxlaer… - Seminars in …, 2020 - Springer
Leishmaniasis is a disease complex caused by 20 species of protozoan parasites belonging
to the genus Leishmania. In humans, it has two main clinical forms, visceral leishmaniasis …

[HTML][HTML] Comparative study of rK39 Leishmania antigen for serodiagnosis of visceral leishmaniasis: systematic review with meta-analysis

Z Maia, M Lírio, S Mistro, CMC Mendes… - PLoS neglected …, 2012 - journals.plos.org
Background The rK39 recombinant protein is derived from a specific antigen produced by
the Leishmania donovani complex, and has been used in the last two decades for the …

[HTML][HTML] Canine visceral leishmaniasis: Diagnosis and management of the reservoir living among us

BL Travi, A Cordeiro-da-Silva… - PLoS neglected …, 2018 - journals.plos.org
This article reviews essential topics of canine visceral leishmaniasis (CVL) due to
Leishmania infantum infection. It focuses on the current serological and molecular …